BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21152944)

  • 1. Rituximab in the treatment of acute cellular rejection of renal allograft with CD20-positive clusters in the infiltrate.
    Vega J; Goecke H; Carrasco A; Escobar C; Escobar M; Espinosa R; Méndez G; de Los Ángeles Rodríguez M
    Clin Exp Nephrol; 2011 Apr; 15(2):308-11. PubMed ID: 21152944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal analysis of T and B cell phenotype and function in renal transplant recipients with or without rituximab induction therapy.
    Kamburova EG; Koenen HJ; van den Hoogen MW; Baas MC; Joosten I; Hilbrands LB
    PLoS One; 2014; 9(11):e112658. PubMed ID: 25393622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection.
    Theruvath TP; Saidman SL; Mauiyyedi S; Delmonico FL; Williams WW; Tolkoff-Rubin N; Collins AB; Colvin RB; Cosimi AB; Pascual M
    Transplantation; 2001 Jul; 72(1):77-83. PubMed ID: 11468538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nodular B-cell aggregates associated with treatment refractory renal transplant rejection resolved by rituximab.
    Lehnhardt A; Mengel M; Pape L; Ehrich JH; Offner G; Strehlau J
    Am J Transplant; 2006 Apr; 6(4):847-51. PubMed ID: 16539643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late-onset neutropenia and acute rejection in ABO-incompatible kidney transplant recipients receiving rituximab and mycophenolate mofetil.
    Kabei K; Uchida J; Iwai T; Yamasaki T; Kuwabara N; Naganuma T; Kumada N; Nakatani T
    Transpl Immunol; 2014 Aug; 31(2):92-7. PubMed ID: 24932811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late acute antibody mediated rejection after nine years of renal transplantation.
    Halim MA; Al-Otaibi T; Al-Waheeb S; Tawab KA; El Kholy O; Nair P; Said T; Narayanan Nampoory MR
    Saudi J Kidney Dis Transpl; 2010 Nov; 21(6):1111-4. PubMed ID: 21060182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refractory CD20 Positive Cellular Rejection in Living Kidney Transplant: A Case Report and Review of Literature.
    Akl AI; Sheashaa HA; Rahim MA; El Hadedy MA; Refaie AF
    Exp Clin Transplant; 2019 Dec; 17(6):823-827. PubMed ID: 29534659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, prospective trial of rituximab for acute rejection in pediatric renal transplantation.
    Zarkhin V; Li L; Kambham N; Sigdel T; Salvatierra O; Sarwal MM
    Am J Transplant; 2008 Dec; 8(12):2607-17. PubMed ID: 18808404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refractory acute kidney transplant rejection with CD20 graft infiltrates and successful therapy with rituximab.
    Alausa M; Almagro U; Siddiqi N; Zuiderweg R; Medipalli R; Hariharan S
    Clin Transplant; 2005 Feb; 19(1):137-40. PubMed ID: 15659147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
    Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J
    Clin Transpl; 2014; ():223-30. PubMed ID: 26281149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early and late humoral rejection: a clinicopathologic entity in two times.
    Péfaur J; Díaz P; Panace R; Salinas P; Fiabane A; Quinteros N; Chea R; Naranjo E; Wurgaft A; Beltran E; Elgueta S; Wegmann ME; Gajardo JG; Contreras L
    Transplant Proc; 2008 Nov; 40(9):3229-36. PubMed ID: 19010241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group.
    Sollinger HW
    Transplantation; 1995 Aug; 60(3):225-32. PubMed ID: 7645033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-mediated rejection and treatment in pediatric patients: one center's experience.
    Gulleroglu K; Baskin E; Bayrakci US; Turan M; Ozdemir BH; Moray G; Karakayali H; Haberal M
    Exp Clin Transplant; 2013 Oct; 11(5):404-7. PubMed ID: 24128133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New treatments for acute humoral rejection of kidney allografts.
    Venetz JP; Pascual M
    Expert Opin Investig Drugs; 2007 May; 16(5):625-33. PubMed ID: 17461736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pinpoint targeted immunosuppression: anti-CD20/MMF desensitization with anti-CD25 in successful ABO-incompatible kidney transplantation without splenectomy.
    Saito K; Nakagawa Y; Suwa M; Kumagai N; Tanikawa T; Nishiyama T; Ueno M; Gejyo F; Nishi S; Takahashi K
    Xenotransplantation; 2006 Mar; 13(2):111-7. PubMed ID: 16623803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary immunosuppression with mycophenolate mofetil and antithymocyte globulin for kidney transplant recipients of a suboptimal graft.
    Grinyó JM; Gil-Vernet S; Seron D; Hueso M; Fulladosa X; Cruzado JM; Moreso F; Fernandez A; Torras J; Riera L; Castelao AM; Alsina J
    Nephrol Dial Transplant; 1998 Oct; 13(10):2601-4. PubMed ID: 9794567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab therapy for acute humoral rejection after kidney transplantation.
    Faguer S; Kamar N; Guilbeaud-Frugier C; Fort M; Modesto A; Mari A; Ribes D; Cointault O; Lavayssière L; Guitard J; Durand D; Rostaing L
    Transplantation; 2007 May; 83(9):1277-80. PubMed ID: 17496547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of acute antidonor antibody-mediated humoral rejection after renal transplantation with specific consideration of serial graft biopsy histology.
    Shimizu T; Tokiwa M; Yamaguchi Y
    Clin Transplant; 2002; 16 Suppl 8():62-7. PubMed ID: 12464135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of early mixed cellular and humoral renal allograft rejection with tacrolimus and mycophenolate mofetil.
    Sun Q; Liu ZH; Cheng Z; Chen J; Ji S; Zeng C; Li LS
    Kidney Int; 2007 Jan; 71(1):24-30. PubMed ID: 16969384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Induction treatment by combining immunoglobulins, plasmapheresis and rituximab in hypersensitive patients receiving cadaveric renal allograft].
    Rufino Hernández JM; Cabello Moya E; González-Posada JM; Hernández Marrero D; Pérez Tamajón L; Marrero Miranda D; García Rebollo S; Martín Urcuyo B; Rodríguez Hernández A; Franco Maside A; Barrios del Pino Y; Rodríguez Rodríguez R; Maceira Cruz B; Torres Ramírez A; Salido Ruiz E
    Nefrologia; 2010; 30(2):252-7. PubMed ID: 20098463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.